619 related articles for article (PubMed ID: 17449373)
1. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
[No Abstract] [Full Text] [Related]
2. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
3. [ANCA-associated vasculitis. New concepts and strategies in therapy].
de Groot K; Haubitz M; Haller H
Internist (Berl); 2000 Oct; 41(10):1112-9. PubMed ID: 11084898
[No Abstract] [Full Text] [Related]
4. [Pulmonary vasculitis].
Cordier JF
Rev Med Interne; 2002 Dec; 23 Suppl 5():547s-548s. PubMed ID: 12701246
[No Abstract] [Full Text] [Related]
5. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
6. [Vasculitides: nosological classification and targeted therapies].
Guillevin L
Rev Prat; 2008 Mar; 58(5):479. PubMed ID: 18524102
[No Abstract] [Full Text] [Related]
7. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
8. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies for systemic necrotizing vasculitides.
Guillevin L; Pagnoux C
Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
[TBL] [Abstract][Full Text] [Related]
11. Biological therapies: new treatment options for ANCA-associated vasculitis?
Aries PM; Lamprecht P; Gross WL
Expert Opin Biol Ther; 2007 Apr; 7(4):521-33. PubMed ID: 17373903
[TBL] [Abstract][Full Text] [Related]
12. [Churg-Strauss syndrome].
Gross WL
Internist (Berl); 2001 Dec; 42(12):1583-4, 1587-90. PubMed ID: 11793597
[No Abstract] [Full Text] [Related]
13. [Churg-Strauss syndrome].
Lhote F
Presse Med; 2007 May; 36(5 Pt 2):875-89. PubMed ID: 17408916
[TBL] [Abstract][Full Text] [Related]
14. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
Holle JU
Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
[No Abstract] [Full Text] [Related]
15. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.
Haubitz M
Vasa; 2007 May; 36(2):81-9. PubMed ID: 17708098
[TBL] [Abstract][Full Text] [Related]
16. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
17. [Classification of systemic vasculatides].
Guillevin L; Pagnoux C; Guilpain P
Presse Med; 2007 May; 36(5 Pt 2):845-53. PubMed ID: 17408915
[TBL] [Abstract][Full Text] [Related]
18. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.
Frankel SK; Sullivan EJ; Brown KK
Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444
[TBL] [Abstract][Full Text] [Related]
19. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
20. L6. Eosinophilic granulomatosis with polyangiitis: future therapies.
Moosig F
Presse Med; 2013 Apr; 42(4 Pt 2):510-2. PubMed ID: 23453508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
